Skip to Content

Russell Inv Equity Income A RSQAX

Medalist Rating as of | See Russell Investments Investment Hub
  • NAV / 1-Day Return 24.70  /  −0.52 %
  • Total Assets 188.6 Mil
  • Adj. Expense Ratio
    1.120%
  • Expense Ratio 1.120%
  • Distribution Fee Level Above Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.26%
  • Turnover 31%

USD | NAV as of Apr 15, 2024 | 1-Day Return as of Apr 15, 2024, 10:57 PM GMT+0

Morningstar’s Analysis RSQAX

Will RSQAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Russell Inv Equity Income A's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RSQAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

E-mini S&P 500 Future Mar 24

5.85 11.7 Mil

U.S. Cash Management Fund

5.40 10.8 Mil
Cash and Equivalents

JPMorgan Chase & Co

2.26 4.5 Mil
Financial Services

Berkshire Hathaway Inc Class B

2.07 4.1 Mil
Financial Services

CVS Health Corp

1.87 3.7 Mil
Healthcare

Wells Fargo & Co

1.76 3.5 Mil
Financial Services

Johnson & Johnson

1.74 3.5 Mil
Healthcare

Merck & Co Inc

1.58 3.2 Mil
Healthcare

Citigroup Inc

1.41 2.8 Mil
Financial Services

Medtronic PLC

1.31 2.6 Mil
Healthcare